CN1071114C - 可注射咪斯钠溶液 - Google Patents

可注射咪斯钠溶液 Download PDF

Info

Publication number
CN1071114C
CN1071114C CN93118643A CN93118643A CN1071114C CN 1071114 C CN1071114 C CN 1071114C CN 93118643 A CN93118643 A CN 93118643A CN 93118643 A CN93118643 A CN 93118643A CN 1071114 C CN1071114 C CN 1071114C
Authority
CN
China
Prior art keywords
sodium
solution
miaow
injection
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN93118643A
Other languages
English (en)
Chinese (zh)
Other versions
CN1089137A (zh
Inventor
J·恩格尔
E·沃尔海斯
W·迪格
G·卡穆格利亚
D·索尔比尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Pharmaceutical Co ltd
Original Assignee
Asta Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharmaceutical Co ltd filed Critical Asta Pharmaceutical Co ltd
Publication of CN1089137A publication Critical patent/CN1089137A/zh
Application granted granted Critical
Publication of CN1071114C publication Critical patent/CN1071114C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CN93118643A 1992-10-08 1993-10-05 可注射咪斯钠溶液 Expired - Lifetime CN1071114C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4233842A DE4233842A1 (de) 1992-10-08 1992-10-08 Mesna Injektionslösungen
DEP4233842.5 1992-10-08

Publications (2)

Publication Number Publication Date
CN1089137A CN1089137A (zh) 1994-07-13
CN1071114C true CN1071114C (zh) 2001-09-19

Family

ID=6469925

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93118643A Expired - Lifetime CN1071114C (zh) 1992-10-08 1993-10-05 可注射咪斯钠溶液

Country Status (28)

Country Link
US (2) US5728738A (fi)
EP (1) EP0591710B1 (fi)
JP (1) JP3636372B2 (fi)
KR (1) KR100364466B1 (fi)
CN (1) CN1071114C (fi)
AT (1) ATE139693T1 (fi)
AU (1) AU667129B2 (fi)
BR (1) BR9304151A (fi)
CA (1) CA2107961C (fi)
CZ (1) CZ284584B6 (fi)
DE (2) DE4233842A1 (fi)
DK (1) DK0591710T3 (fi)
EG (1) EG20308A (fi)
ES (1) ES2089661T3 (fi)
FI (1) FI111804B (fi)
GR (1) GR3020669T3 (fi)
HK (1) HK7397A (fi)
HR (1) HRP931267B1 (fi)
HU (1) HU217123B (fi)
IL (1) IL107187A (fi)
NO (1) NO303712B1 (fi)
NZ (1) NZ248873A (fi)
RU (1) RU2105550C1 (fi)
SI (1) SI9300525A (fi)
SK (1) SK279609B6 (fi)
TW (1) TW279131B (fi)
UA (1) UA26134C2 (fi)
ZA (1) ZA937458B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US6031006A (en) * 1999-10-21 2000-02-29 Bionumerik Pharmaceuticals, Inc. Method of treating diabetic nephropathy
TW201036529A (en) 2009-03-25 2010-10-01 Askey Computer Corp A liquid crystal anti-freeze method and a liquid crystal module using the liquid crystal anti-freeze method
UA74097U (ru) * 2012-07-24 2012-10-10 Николай Иванович Гуменюк Способ изготовления средства для лечения туберкулеза
US10092312B2 (en) * 2013-05-07 2018-10-09 Auxin Surgery Sa Device for chemically assisted dissection
BR112018068619A2 (pt) * 2016-03-14 2019-02-05 Auxin Surgery Sa ?dispositivo, método e formulação para dissecção assistida quimicamente?
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111770A1 (de) * 1981-03-25 1982-10-07 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin Verwendung von dimercaptopropansulfonsaeure und dimercaptobernsteinsaeure zur herstellung von pharmazeutischen mitteln
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
ATE65402T1 (de) * 1988-03-19 1991-08-15 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE MERCK LNDEX 11版 1989.1.1 Merck co，IN *

Also Published As

Publication number Publication date
HU217123B (hu) 1999-11-29
HRP931267B1 (en) 1997-08-31
NO933590L (no) 1994-04-11
IL107187A (en) 1999-03-12
CN1089137A (zh) 1994-07-13
JP3636372B2 (ja) 2005-04-06
SK279609B6 (sk) 1999-01-11
EG20308A (en) 1998-10-31
KR100364466B1 (ko) 2003-01-29
KR940008678A (ko) 1994-05-16
GR3020669T3 (en) 1996-10-31
DE4233842A1 (de) 1994-04-14
ZA937458B (en) 1994-04-26
SI9300525A (en) 1994-06-30
DK0591710T3 (da) 1996-09-30
HK7397A (en) 1997-01-24
AU4888393A (en) 1994-04-21
IL107187A0 (en) 1994-01-25
ES2089661T3 (es) 1996-10-01
FI934410A0 (fi) 1993-10-07
FI111804B (fi) 2003-09-30
SK107993A3 (en) 1994-05-11
CZ284584B6 (cs) 1999-01-13
HU9302837D0 (en) 1993-12-28
DE59303067D1 (de) 1996-08-01
TW279131B (fi) 1996-06-21
AU667129B2 (en) 1996-03-07
JPH06263629A (ja) 1994-09-20
BR9304151A (pt) 1994-06-07
RU2105550C1 (ru) 1998-02-27
EP0591710B1 (de) 1996-06-26
CA2107961A1 (en) 1994-04-09
EP0591710A1 (de) 1994-04-13
NZ248873A (en) 1995-10-26
NO933590D0 (no) 1993-10-07
NO303712B1 (no) 1998-08-24
ATE139693T1 (de) 1996-07-15
UA26134C2 (uk) 1999-06-07
CZ209793A3 (en) 1994-04-13
FI934410A (fi) 1994-04-09
HRP931267A2 (en) 1994-12-31
US5696172A (en) 1997-12-09
US5728738A (en) 1998-03-17
CA2107961C (en) 2003-03-25
HUT65096A (en) 1994-04-28

Similar Documents

Publication Publication Date Title
US3577522A (en) Methods for the treatment of shock with ethylene oxide-polypropylene glycol condensates as blood plasma substitutes
CN1071114C (zh) 可注射咪斯钠溶液
FI66534C (fi) Foerfarande foer framstaellning av immunoglobulin som innehaoller antikroppar och aer laempligt foer intravenoes administration
HU229571B1 (en) Aqueous compositions containing moxifloxacin and common salt and process for its preparation
CN104704007A (zh) 烷基化环糊精组合物及其制备和使用方法
JPH10503603A (ja) コンタクトレンズ処置用の生理的食塩水
CA1219211A (en) Stabilized gamma globulin concentrate
CN105073785A (zh) 烷基化环糊精组合物及其制备和使用方法
FI81962C (fi) Foerfarande foer framstaellning av en stabil doseringsform av en pge2-foerening.
US11324692B2 (en) Method to prepare pharmaceutical compositions of suggamadex
CN1210032C (zh) 含有卡马西平或其衍生物的肠胃外给药制剂
US5955456A (en) Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
EA006220B1 (ru) Многодозовые эритропоэтиновые составы
CN1186094C (zh) 具有促思维记忆功能的吡拉西坦药物组合物及其制备方法
SK44795A3 (en) Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
US5834520A (en) Container for injectable mesna solutions
RU2725962C2 (ru) Способ приготовления фармацевтической композиции на основе золедроновой кислоты в виде раствора для инфузий для лечения онкологических заболеваний и способ получения фармацевтической композиции на основе золедроновой кислоты в виде концентрата для приготовления раствора для инфузий для лечения онкологических заболеваний
CN1398636A (zh) 胸腺肽组合物注射剂及其制备方法
CN1301178A (zh) 含前列腺素类化合物和苄醇的溶液
EP1551464B1 (en) Use of paraben comprising compositions
JPWO2020232424A5 (fi)
EP3932391A1 (en) Method to prepare pharmaceutical compositions
KR810001235B1 (ko) 정맥주사용 동결 건조 천연 감마 글로블린제의 제조방법
EA012368B1 (ru) Композиции ифосфамида для парентерального введения и способ их получения
CN1861067A (zh) 硫普罗宁输液剂及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CX01 Expiry of patent term

Expiration termination date: 20131005

Granted publication date: 20010919